Mindpeak logo

Mindpeak

Our mission is to enable personalised cancer treatment through AI tissue diagnostics

49 employees · est. 2018 · Hamburg, Germany

VS
Veracyte, Inc. logo

Veracyte, Inc.

Cancer Genomic Testing & Molecular Diagnostics | Veracyte Inc.

753 employees · est. 2008 · South San Francisco, United...

Veracyte, Inc. is the older company (2018 vs 2008); Veracyte, Inc. is the larger of the two.

Side-by-Side Comparison

Mindpeak Veracyte, Inc.
Founded
2018 2008 older
Headquarters
Hamburg, Germany South San Francisco, United States
Employees
49 753 larger
Industry
AI, Biotechnology, Health Care Biotechnology, Health Care
Funding Stage
Series A IPO
Total Funding
$19.67M $1.15B
Funding Rounds
4 12
Services
AI-driven Biomarker Discovery, Clinical Trial Support, Pathology Integration, Next-Gen Biomarkers Deployment, Tissue Computation Genomic Sequencing Classifier, Bladder Genomic Classifier, Prostate Genomic Classifier, Breast Risk of Recurrence Test, Monitoring Test for MIBC
Target Customers
Pharmaceutical Companies, Diagnostic Laboratories, Biopharma Researchers, Oncology Departments Clinicians, Cancer Patients, Healthcare Providers, Research Scientists, Oncology Clinics
Taxonomy
AI Tissue Diagnostics, Personalized Cancer Treatment, Medical Image Analysis, Automation Tools, Visual Diagnosis, Deep Learning, Cancer Diagnostics, Pathology, Biomarker Quantification, Cell Quantification, Cancer Specialists Support, Diagnostic Reliability, Diagnostic Reproducibility Genomic Diagnostics, Cancer Diagnostics, Molecular Diagnostics, Thyroid Cancer Testing, Lung Cancer Testing, Breast Cancer Testing, Idiopathic Pulmonary Fibrosis Testing, Lymphoma Subtyping, Diagnostic Instrument Platform, Patient Care Improvement, Genomic Science Advancements, Cancer Treatment Guidance, Clinical Decision Support, Global Diagnostics Company, Cost-effective Diagnostics
Website
mindpeak.ai veracyte.com
Mindpeak logo

About Mindpeak

Mindpeak, founded in 2018 and headquartered in Germany, is revolutionizing personalized cancer treatment through AI tissue diagnostics. The company partners with leading pathology and university labs to alleviate the growing workload on cancer specialists by offering cutting-edge automation tools po...

Veracyte, Inc. logo

About Veracyte, Inc.

Veracyte, Inc., founded in 2008 and headquartered in the United States, operates within the Biotechnology and Health Care industries. The company's slogan, "Cancer Genomic Testing & Molecular Diagnostics | Veracyte Inc.," encapsulates its core mission: delivering high-value diagnostic insights that...

Be first to know when either one moves

Funding rounds, hiring surges, leadership changes and stack switches at Mindpeak and Veracyte, Inc. — tracked continuously, sent the day they land.

Watch both — free

Funding, hiring, leadership and stack changes at Mindpeak and Veracyte, Inc. — by email.

Frequently Asked Questions

Mindpeak — Our mission is to enable personalised cancer treatment through AI tissue diagnostics. Veracyte, Inc. — Cancer Genomic Testing & Molecular Diagnostics | Veracyte Inc.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Mindpeak has raised $19.67M while Veracyte, Inc. has raised $1.15B.
Mindpeak and Veracyte, Inc. operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Mindpeak with someone else

Start typing a company name or domain.

One analytics cookie (Google Analytics). Cookie Policy